Menu
  • Join
  • Login
  • Contact
 

Search abstracts


chronic heart failure (CHF) is the most frequent complication of many heart diseases; the most common one of them is coronary heart disease.

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: KRASNOVA, Marina (Saint-Petersburg State Chemical-Pharmaceuitical Academy, Center of Experimental Pharmacology,, Saint-Petersburg, Russian Federation)
  • Co-author(s): Dmitriy Ivkin: Center of Experimental Pharmacology, Saint-Petersburg State Chemical-Pharmaceuitical Academy, Saint-Petersburg, Russian Federation
    Marina Krasnova: Center of Experimental Pharmacology, Saint-Petersburg State Chemical-Pharmaceuitical Academy, Saint-Petersburg, Russian Federation
    Arina Ivkina: Center of Experimental Pharmacology, Saint-Petersburg State Chemical-Pharmaceuitical Academy, Saint-Petersburg, Russian Federation
    Andrey Teslev: Saint-Petersburg State Chemical-Pharmaceuitical Academy, Saint-Petersburg, Russian Federation
    Andrey Karpov: First Pavlov State Medical University of St. Peterburg, Saint-Petersburg, Russian Federation
  • Abstract:

    Backgrounds

    Chronic heart failure (CHF) is the most frequent complication of many heart diseases.

    Aims

    Assessment of influence of 4-(oxo-3-ethoxypropanamide)benzoic acid on the development of experimental post-infarction CHF.

    Methods

    The CHF model was reproduced by ligation of the left coronary artery in outbred male rats (post-infarction chronic heart

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses